Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 24: The SELECT Trial
Author(s): Subodh Verma Added: 5 months ago
AHA Conference 2024 - Outcomes of SELECT show that semaglutide treatment in obese or overweight patients with prior history of coronary artery bypass graft (CABG) surgery reduces the risk of cardiovascular events.Dr Subodh Verma (University of Toronto, Toronto, CA) joins us onsite at AHA Conference to discuss the findings from SELECT (NCT03574597).SELECT is a randomized, double-blind, placebo… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Sex Differences in Spontaneous Coronary Artery Dissection
Author(s): Aishat F Mustapha , Anna M Goebel , Bryan J Wells Added: 1 year ago

Imaging & Diagnostics

Prevention & Chronic Conditions
CRT 24: SYNTAX: PCI With TAXUS and CABG in Complex Coronary Disease
Author(s): Patrick W Serruys Added: 1 year ago
CRT 2024 — Prof Patrick W Serruys (National University of Ireland, Galway, US) joins us to discuss learning from the SYNTAX trial.The SYNTAX trial is a randomized controlled trial designed to evaluate the efficacy and safety of percutaneous coronary intervention (PCI) with polymer-based paclitaxel-eluting TAXUS stents versus coronary artery bypass grafting (CABG) in patients with complex coronary… View more

Vascular Disease and Surgery

Intervention
ESC 24 Hot Line Discussion: The SWEDEGRAFT Trial
Author(s): Harriette Van Spall , Stefan James Added: 8 months ago
ESC Congress 2024 — SWEDEGRAFT does not support the routine use of no-touch vein harvest compared to the standard technique.Dr Harriette Van Spall (McMaster University, CA) sits down with principal investigator Prof Stefan James (Uppsala University, SE) to discuss results of the SWEDEGRAFT trial (NCT03501303; Uppsala University).The SWEDEGRAFT trial is a prospective, binational, multicenter, open… View more

Vascular Disease and Surgery

Intervention
Anomalous Coronary Artery Origin
Author(s): Luai Madanat , Ahmad Jabri , Michael Gallagher , et al Added: 1 month ago

Imaging & Diagnostics

Prevention & Chronic Conditions
Left Main Percutaneous Coronary Revascularization
Author(s): Abdulrahman Almoghairi , Nayef Al-Asiri , Khalid Al Johani , et al Added: 1 year ago

Imaging & Diagnostics

Intervention
MI and Non-obstructive Coronary Arteries
Author(s): Yetunde A Fatade , Noah A Newman , Nidhi H Patel , et al Added: 10 months ago

Prevention & Chronic Conditions

MI/ACS
AFSymposium 24: Long-Term Effects of PFA on Coronary Arteries
Author(s): Yury Malyshev Added: 1 year ago
AF Symposium 24 — Dr Yury Malyshev (Mount Sinai Hospital, US) joins us to discuss the findings from three studies focusing on the long-term effects of pulsed-field ablation (PFA) on coronary arteries.QuestionsWhat is known currently about the effect of PFA in Coronary Arteries? What is the importance of this topic?What was the study design and cohort?What are the key findings?Who are the take… View more

Electrophysiology & Arrhythmia
Author(s): Rasha Al-Lamee , Michael Foley Added: 1 year ago
ACC.24 — Investigators, Dr Rasha K Al-Lamee and Dr Michael Foley (Imperial College London, UK) joined us to discuss the ORBITA COSMIC trial (NCT04892537).This randomized, double-blinded, placebo-controlled trial investigated the effects of coronary sinus reducer (CSR) as compared to placebo on myocardial perfusion via MRI, exercise duration, and symptoms in patients with refractory angina and… View more

Prevention & Chronic Conditions
The FLEX FIRST AV Registry
Author(s): Ari Kramer Added: 1 week ago
Real-world outcomes from the FLEX Vessel Prep (VP) system in arteriovenous fistulae and grafts show good safety results with no serious adverse events at 30 days and a high six-month primary patency rate.Dr Ari Kramer (Spartanburg Medical Centre, Spartanburg, US) joins us to discuss outcomes from the prospective, multi-centre, observational study using the FLEX FIRST AV registry (NCT05616104;… View more

Intervention

Vascular Disease and Surgery